Abbott Laboratories (ABT) Q4 2020 Earnings Results

Abbott Labs Beats on EPS, Stock Down 0.38%

Abbott Labs reported a better-than-expected EPS, which indicates solid earnings performance. However, the stock reacted negatively, declining by 0.38%. This could suggest that investors were looking for more comprehensive revenue details or guidance, which were not provided.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.45	N/A	+6.54%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management conveyed a sense of cautious optimism regarding future growth. They emphasized the strength of their diagnostics business despite broader market challenges.

Management highlighted strong performance in their diagnostics segment.

They acknowledged challenges in the market but expressed confidence in their product pipeline.

Abbott Labs Beats on EPS, Stock Down 0.38%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Labs Beats on EPS, Stock Down 0.38%

Key numbers

Management commentary